Products for Research Use Only
RegisterLogin

SPA-10091-HCl

CAT: 1568-C04931-1mgSize: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1568-C04931-1mgSize:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Target
DOT1
Applications
Epigenetics
Additionnal Information
SPA-10091-HCl is a degrader of DOT1L that selectively degrades DOT1L protein through the nuclear ubiquitin-proteasome pathway, thereby suppressing H3K79 methylation in CRPC cells. It also inhibits DOT1L enzymatic activity with an IC50 of 0.87 μM, induces apoptosis, and significantly reduces tumor growth in vivo.

Related Products

CatalogName
C18186-25mgSRT3025 HCl
C17853-5mgSiramesine HCl
C18041-100mgAT7519 HCl
C17092-50mgML133 HCl
C09030-10mgParoxetine HCl
C09055-10mgDaunorubicin HCl
C09063-25mgLurasidone HCl
C09074-200mgBesifloxacin HCl
C17189-10mM/1mLMedetomidine HCl
C09080-50mgEpinephrine HCl

Alternative Products

CatalogName
T207790-01SPA-10091-HCl
abx085369-01SPA-PEG-SPA
HO025025-6K-01SPA-PEG-SPA, 6K
HO025025-8K-01SPA-PEG-SPA, 8K
HO025025-500-01SPA-PEG-SPA, 500
HO025025-600-01SPA-PEG-SPA, 600
HO025025-400-01SPA-PEG-SPA, 400
HO025025-200-01SPA-PEG-SPA, 200
HO025025-800-01SPA-PEG-SPA, 800
HO025025-10K-01SPA-PEG-SPA, 10K

Popular Products